Ex-Div Reminder for Solar Senior Capital Limited (SUNS)

Looking at the universe of stocks we cover at Dividend Channel, on 8/19/14, Solar Senior Capital Limited (SUNS) will trade ex-dividend, for its monthly dividend of $0.1175, payable on 9/3/14. As a percentage of SUNS's recent stock price of $16.27, this dividend works out to approximately 0.72%, so look for shares of Solar Senior Capital Limited to trade 0.72% lower — all else being equal — when SUNS shares open for trading on 8/19/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for SUNS, showing historical dividends prior to the most recent $0.1175 declared by Solar Senior Capital Limited:

SUNS+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from SUNS is likely to continue, and whether the current estimated yield of 8.67% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of SUNS shares, versus its 200 day moving average:

Solar Senior Capital Limited 200 Day Moving Average Chart

Looking at the chart above, SUNS's low point in its 52 week range is $15.90 per share, with $19.00 as the 52 week high point — that compares with a last trade of $16.27.

In Friday trading, Solar Senior Capital Limited shares are currently up about 0.4% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says